NewsFeed Voices Science Insight Innovation
December, 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines
Fotios Barkas/ LinkedIn
Sep 1, 2025, 07:37

Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines

Fotios Barkas, Assistant Professor of Internal Medicine University of Ioannina, shared a noteworthy post on LinkedIn:

“Just released in ESC2025: Updated Dyslipidemia Guidelines
Key highlights:

  • CAC Score for risk
  • LDL-C cutoffs for LLL initiation
  • Bempedoic acid and Evinacumab
  • Lp(a) ≥50 mg/dL as a cutoff
  • Intensification of LLM post-ACS
  • EPA only
  • Volanesorsen in FCS, statins in HIV, and anthracyclin-induced cardiotoxicity
  • Dietary supplements”

Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines

Stay updated with Hemostasis Today.

Bempedoic Acid CAC Score Cardiotoxicity cardiovascular risk Dietary Supplements Dyslipidemia Guidelines EPA ESC 2025 European Atherosclerosis Society Evinacumab Familial Chylomicronemia Syndrome Health Hematology Hemostasis Today HIV LDL Cholesterol Lipid Lowering Therapy Lipoprotein a Medicine Post ACS Management statins Volanesorsen
NewsFeed